The Onchocerciasis Vaccine for Africa—TOVA—Initiative

• Peter J. Hotez,

  Affiliation Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Maria Elena Bottazzi,

  Affiliation Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Bin Zhan,

  Affiliation Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Benjamin L. Makepeace,

  Affiliation Institute of Infection and Global Health, University of Liverpool, Liverpool, England

  ⨯
• Thomas R. Klei,

  Affiliation Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, United States of America

  ⨯
• David Abraham,

  Affiliation Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

  ⨯
• David W. Taylor ,

  * E-mail: SLustigman@NYBloodCenter.org (SL); David.W.Taylor@ed.ac.uk (DWT)

  Affiliation Division of Pathway Medicine, School for Biomedical Studies, University of Edinburgh, Edinburgh, Scotland

  ⨯
• Sara Lustigman

  * E-mail: SLustigman@NYBloodCenter.org (SL); David.W.Taylor@ed.ac.uk (DWT)

  Affiliation Laboratory of Molecular Parasitology, Lindsley F Kimball Research Institute, New York Blood Center, New York, New York, United States of America

  ⨯